Federal Judge Slams Barr, DOJ As ‘Disingenuous’ While Ordering Release Of Mueller Report Memos

District Court Judge Amy Berman Jackson criticized former Attorney General William Barr and the Department of Justice in a ruling ordering the release of a memo related to the Mueller report. Berman Jackson wrote in her partially-redacted ruling that the federal government must release a memo analyzing whether or not the Justice Department should have charged former President Donald Trump with a crime in connection with the Mueller probe. In doing so, she claimed that Barr was “disingenuous” in his characterization of the Mueller report’s findings. Barr released a summary of Special Counsel Robert Mueller’s report on alleged Russian involvement in the 2016 presidential election before the report was redacted and released to the public.

In the summary, Barr noted the principal finding of the report, that “the investigation did not establish that members of the Trump Campaign conspired or coordinated with the Russian government in its election interference activities,” even as “there were two main Russian efforts to influence the 2016 election.” Mueller later objected to Barr’s characterization, saying that it did not “did not fully capture the context, nature and substance” of the special counsel’s investigation. Mueller did not, however, say that he believed Barr’s summary was inaccurate, but that the media and congressional Democrats misinterpreted the announcement. The Center for Responsibility and Ethics in Washington (CREW), a liberal watchdog group, filed a Freedom of Information Act (FOIA) request demanding that the Justice Department release “all documents pertaining to the views OLC [Office of Legal Counsel] provided Attorney General Barr on whether the evidence developed by Special Counsel Mueller is sufficient to establish that the President committed an obstruction-of-justice offense.” Although the Justice Department released 33 documents pursuant to the FOIA request, it withheld 28. In directing the Justice Department to release one of the 28 withheld documents, Berman Jackson wrote that the “DOJ has been disingenuous to this Court with respect to the existence of a decision-making process that should be shielded by the deliberative process privilege.” The deliberative process privilege refers to a rule that allows the federal government to shield documents that consist of “advisory opinions, recommendations and deliberations” towards decision making. “The review of the document in camera reveals that there was no decision actually being made as to whether the then-President should be prosecuted,” Berman Jackson wrote. The Department of Justice will have two weeks to either release the document in question or appeal Berman Jackson’s order.

https://dailycaller.com/2021/05/04/amy-berman-jackson-slams-william-barr-doj/

https://www.nytimes.com/interactive/2019/03/24/us/politics/barr-letter-mueller-report.html

Pfizer sees ‘durable demand’ for COVID-19 vaccine as it boosts sales forecast

Pfizer Inc on Tuesday raised its forecast for 2021 COVID-19 vaccine sales by more than 70 per cent to US$26 billion and said demand from governments around the world trying to halt the pandemic could contribute to its growth for years to come. The company said it expects by the end of this month to file for full approval of the vaccine for people over the age of 16 in the United States, where it is currently only authorized for emergency use. It also expects to hear soon from U.S. regulators on the expansion of the vaccine’s emergency use authorization (EUA) for children ages 12-15. Revenue from the vaccine – developed with German partner BioNTech SE – is expected to account for more than one third of Pfizer’s full-year sales this year. The forecast is based on already signed contracts for 1.6 billion vaccine doses to be delivered this year. The company said it expects to sign more deals for this year and is in supply talks with several countries for 2022 and beyond. “Based on what we’ve seen, we believe that a durable demand for our COVID-19 vaccine – similar to that of the flu vaccines – is a likely outcome,” Chief Executive Albert Bourla said.

The two-shot vaccine was Pfizer’s top-selling product in the first quarter. Expenses and profit from the vaccine are split 50-50 between Pfizer and BioNTech. Given persistent infections globally and ongoing discussions with governments, Mizuho analyst Vamil Divan said the 2021 forecast could increase further and also spill over to latter years. Daily vaccination rates for adults in the United States have started to slow, off more than 25 per cent since hitting a peak in mid-April. Authorization in younger children would expand the vaccine-eligible population by millions of people. Pfizer said it expects to have safety and efficacy data for children ages 2-to-11 in September, when it plans to ask for further expansion of the EUA for that age group. Pfizer and BioNTech aim to produce up to 2.5 billion COVID-19 vaccine doses this year, 900 million of which are not yet included in the New York-based drugmaker’s sales forecast.

If Pfizer sells that number of doses at similar prices, the vaccine’s sales in 2021 could be more than 50 per cent above the projected US$26 billion. Moderna In has forecast US$18.4 billion in 2021 sales of its similar COVID-19 vaccine. Pfizer has said it expects to profit from the vaccine, while some drugmakers including Johnson & Johnson have said their vaccine will be sold on a not-for-profit basis until the end of the pandemic. Pfizer aims to manufacture at least 3 billion doses of the vaccine next year. It generated US$3.5 billion in revenue in the first quarter, exceeding analysts’ estimates of US$3.28 billion, according to IBES data from Refinitiv. Total revenue for the quarter of US$14.6 billion, topped analyst forecasts of US$13.5 billion. Pfizer could use the vaccine profit to invest in research and development of other treatments and on deals to spur future growth, said Edward Jones analyst Ashtyn Evans. The company already said it is boosting R&D spending to fuel drug discovery using the messenger RNA technology in the COVID-19 vaccine. The company is developing two flu vaccines that are expected to enter clinical trials in the third quarter. Pfizer shares were up slightly in morning trading.

https://globalnews.ca/news/7832083/pfizer-earnings-covid-vaccine/

>>13586138

Amazing how hard they work to push a false narrative. Thinking after speaking to a few people they are starting to realize the games Rx companies tend to play. Many have pointed out the fact that when there are advertisements for the Vax, it's one of the only meds that doesn't have a laundry list of side affects.

Explainer: COVID-19 vaccine patents dominate global trade talks

World Trade Organization members will assess on Wednesday signs of progress in talks on a proposal by South Africa and India to waive patent rights on COVID-19 vaccines in order to boost supply to developing countries. They want to ease rules of the WTO's Trade-Related Aspects of Intellectual Property (TRIPS) agreement. WTO decisions are based on consensus, so all 164 members need to agree. Ten meetings in seven months have failed to produce a breakthrough, with 60 proposal sponsors from emerging economies, backed by a chorus of campaign groups, Nobel laureates and former world leaders, pitted against richer developed countries, such as Switzerland, the United States and in the European Union, where many pharmaceutical companies are based.

WHERE ARE THE TALKS NOW? After a 10th round of talks on April 30, the waiver proposal's backers said they would revise their text from October in time for the next TRIPS council meeting in the second half of May before a further discussion on June 8-9. The new text could be more limited than the current proposal. Norway's ambassador Dagfinn Sorli, the council chair who will brief Wednesday's WTO General Council, expressed "careful optimism". World Health Organization chief Tedros Adhanom Ghebreyesus talked on Monday of "encouraging progress", but said the process needed to be completed as soon as possible. The WHO said in April that of 700 million vaccines globally administered, only 0.2% had been in low-income countries.

THE PROPONENTS ARGUMENT The Indian/South African proposal in October says property rights such as patents, industrial designs, copyright and protection of undisclosed information hinder timely access to affordable vaccines and medicines essential to combat COVID-19. They say the waiver should last for an unspecified time period, with an annual review until it terminates, and call for unhindered global sharing of technology and know-how. They say there cannot be a repeat of the early years of the HIV/AIDS pandemic, when a lack of access to life-saving medicines cost at least 11 million African lives. The WHO head and 375 civil society and campaign groups such as Doctors Without Borders back the proposal and former leaders from Britain's Gordon Brown to Mikhail Gorbachev of the Soviet Union have jointly written to U.S. President Joe Biden urging him to support it.

THE COUNTER VIEW Big drug companies oppose patent waivers, as do Britain, Switzerland and the United States. The main Western producers are Moderna, Johnson & Johnson, AstraZeneca and jointly Pfizer and BioNTech. They say vaccine development is unpredictable and costly and that strong IP protection helped provide the incentive for the development of vaccines in record time and will do so again in work on tackling new variants or in a future pandemic. Proponents counter that some of the money was public funds. Big Pharma also says vaccine-making is difficult - witness the production problems non-specialist AstraZeneca has faced - so suspending patents alone will not bring more shots. Complex vaccines require deep cooperation between developers and manufacturers. Any failure to make them properly could undermine public confidence in vaccine safety, they say. They also point to over 260 partnership agreements already in place for production and distribution and comment that, under the existing TRIPS agreement, governments can allow produces to make a patented product without the consent of the patent owner. Developing countries have such "compulsory licences" to push down prices for HIV/AIDS medication from 2002 to 2007. The situation though is fluid. In Brazil, the only developing country to oppose the waiver, the Senate has passed a bill to suspend COVID-19 vaccine patents. It has become quieter at the WTO since April. The White House said last week it was considering options to maximise global supply of vaccines, including backing the waiver.

https://www.reuters.com/business/healthcare-pharmaceuticals/covid-19-vaccine-patents-dominate-global-trade-talks-2021-05-05/

>>13586212

>not be the ones announcing to the world that their loved one is an inhuman monster.

Imagining the shame and hurt these family members might feel, especially if they are completely innocent, probably to embarrassing to speak of .

>>13586232

Certainly would, can't imagine how devastating it would be for them..almost like Jekyll and Hyde..

>>13586229

All roads of this kind lead to money and power at the expense of everyday people.

>>13586246

Thinking his whole life is shopped..sorry had to say it, kek.

>>13586168

>>13586168

Joe looks shopped, not even close to a natural pose, Jill is questionable also..

Facebook Board to reveal decision on Trump ban at 10 am today

https://citizenfreepress.com/breaking/facebook-board-to-reveal-decision-on-trump-ban-at-10-am-today/

The Oversight Board

https://www.oversightboard.com/news/

>>13586433

Thinking you might be missing the point, this decision, marks the absolute downfall of this platform and the opening of a public utility..

Why Did Biden Census Bureau Add 2.5 Million More Residents to Blue-State Population Count?

There is something very fishy about the new 2020 Census Bureau data determining which states picked up seats and which states lost seats. Most all of the revisions to the original estimates have moved in one direction: Population gains were added to blue states, and population losses were subtracted from red states. The December revisions in population estimates under the Biden Census Bureau added some 2.5 million blue-state residents and subtracted more than 500,000 red-state residents. These population estimates determine how many electoral votes each state receives for presidential elections and the number of congressional seats in each state. Is this a mere coincidence?

These population estimates determine how many electoral votes each state receives for presidential elections and the number of congressional seats in each state. Remember, the House of Representatives is razor-thin today, with the Democrats sporting just a six-seat majority with five seats currently vacant. So, a switch in a handful of seats in 2022 elections could flip the House and take the gavel away from current Speaker Nancy Pelosi and the Democrats. A shift of 3 million in population is the equivalent of four seats moving from Republican to Democrat. The original projections for the Census reapportionment had New York losing two seats, Rhode Island losing a seat and Illinois perhaps losing two seats. Instead, New York and Illinois only lost one seat, and Rhode Island lost no seats. Meanwhile, Texas was expected to gain three seats, Florida two seats and Arizona one seat. Instead, Texas gained only two seats, Florida only one and Arizona none. Was the Census Bureau count rigged? Was it manipulated by the Biden team to hand more seats to the Democrats and to get more money federal spending is often allocated based on population for the blue states? The evidence is now only circumstantial, but when errors or revisions are almost all only in one direction, the alarm bells appropriately go off.

Here are some of the strange outcomes in the Census revisions just released: No. 1: New York We've been tracking the annual population/migration changes between states since the last census in 2010. Over the past decade, New York LOST about 1.3 million residents on net to other states. (This does not include immigration, births and deaths.) Still, this is a population loss that is the equivalent of two, maybe three, lost congressional seats. But the final numbers ADDED approximately 860,000. That's roughly twice the population of Buffalo and Rochester combined. This is the state that has lost by far the largest population over the past decade. No. 2: Many deep-blue states had 2020 census numbers significantly revised upward from their December estimates: Connecticut, Hawaii, Illinois, Massachusetts, New Jersey, New York, Rhode Island and Vermont. No. 3: Many red states had 2020 census numbers lower than their 2020 estimates: Arizona, North Carolina and South Carolina. No. 4: Going back to the 2010 Census, the final head count in every state was within 0.4% of the original estimate, and 30 of them were within 0.2 percent. This time around, 19 states were more than 1 percent off, 7 were more than 2 percent off, NY was more than 3.8 percent off, and NJ was more than 4.5 percent off. No. 5: Virtually every one of the large deviations from the estimates favored Democrats. Just five states in the 2020 census were within the same margin (0.41 percent) that all states were within from the 2010 census.

Maybe the 2010 estimates were abnormally accurate, or maybe the 2020 estimates were abnormally inaccurate. The Census Bureau needs to tell Congress why these revisions under former President Barack Obama were so much larger than normal and so weighted in one direction: toward the blue states.

https://townhall.com/columnists/stephenmoore/2021/05/04/why-did-biden-census-bureau-add-25-million-more-residents-to-bluestate-population-count-n2588890